Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases.

@article{KowalVern2000DiagnosisAC,
  title={Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases.},
  author={Areta Kowal-Vern and Fermina M. Mazzella and James D. Cotelingam and M Atef Shrit and James T Rector and Harold R. Schumacher},
  journal={American journal of hematology},
  year={2000},
  volume={65 1},
  pages={5-13}
}
Acute erythroleukemia (FAB M6) is a rare heterogeneous disease with an increase in red cell precursors and myeloblasts. Three subsets have been described: M6A (myeloblast-rich erythroleukemia); M6B (proerythroblast-rich erythroleukemia); and M6C (myeloblast- and proerythroblast-rich mixed variant). This study was undertaken to define and compare the clinical courses and survival outcomes among M6A, M6B, and M6C variants of erythroleukemia. Sixty-nine cases of M6 leukemia were categorized as… CONTINUE READING